On November 5, 2020 Cellecta, Inc. reported the launch of its new RNA Spatial Profiling Service using NanoString’s GeoMx Cancer Transcriptome Atlas (CTA) on the GeoMx Digital Spatial Profiler (Press release, Cellecta, NOV 5, 2020, View Source [SID1234570231]). As one of the few designated GeoMx Premier Access Site Partners worldwide, Cellecta offers immediate access to spatial transcriptomic analysis using the NanoString CTA and, upon release, to the GeoMx Whole Transcriptome Atlas.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Researchers are now able to send fresh-frozen or formalin-fixed paraffin-embedded (FFPE) tissue slides to Cellecta for gene expression profiling and spatial analysis to readily obtain comprehensive gene expression profiles of microenvironments and localized regions within tumors and related fixed tissues, as well as corresponding pathway analysis in a variety of visualization formats.
"With the increasing number of researchers interested in assessing the utility of spatial transcriptomics for their tumor samples, we are pleased to welcome Cellecta into our global service network as a GeoMx Premier Access Partner," said Chad Brown, senior vice president of sales and marketing at NanoString. "Their proven skills with RNA expression profiling and functional genomic analysis will be of great benefit to those seeking a greater understanding of tumor biology."
"We are honored to be counted among the handful of GeoMx Premier Access Partners chosen to offer this novel spatial analysis technology to cancer researchers in academia and industry," said Alex Chenchik, Ph.D., president and chief scientific officer of Cellecta. "Given our experience working with RNA throughout the years and especially with our DriverMap Targeted RNA-Seq technology, Digital Spatial Profiling is the logical next step in providing our customers with more comprehensive transcriptomic data to enable valuable research insights that advance the understanding of disease progression and drug development."
For more information Cellecta’s RNA Spatial Profiling Service, visit View Source